Felix Kesselring
Dr. iur., LL.M. (LSE)
CAS ETH RT
CAS ETH RT
Attorney-at-Law
Partner
Head in Pharmaceuticals and Healthcare
Office:
Phone:
+41 58 258 10 00
Languages:
German
English
French
VCard:
Download
Vita
Felix Kesselring advises Swiss and international companies in regulated markets such as healthcare, pharma, medical devices and life sciences. He regularly represents his clients before administrative authorities, administrative criminal authorities and courts.
Admitted to the Swiss Bar since 2009.
Professional background
- Partner, Bratschi Ltd. (since 2020)
- Counsel, CMS von Erlach Poncet Ltd. (2017-2019)
- Seconded legal counsel, Swiss-based multinational pharmaceutical company (2011)
- Associate, VISCHER Ltd (2009-2017)
Training
- CAS ETH in Regulatory Thinking, Federal Institute of Technology Zurich (ETHZ), Switzerland (2024)
- PhD in Law, University of Basel, Switzerland (2017)
- LL.M. in Public Law, London School of Economics and Political Science, London, United Kingdom (2012)
- lic. iur., University of Zurich, Switzerland (2006)
- University Robert Schuman, Strasbourg, France (2004/2005)
Reference cases
- Advising various pharmaceutical companies on negotiating and drafting pharmatypical contracts (research contracts, development contracts, contracts for clinical studies, contract manufacturing agreements, licensing agreements, distribution agreements, etc.)
- Advising various pharmaceutical companies on data protection
- Providing regulatory advice and procedural representation to various pharmaceutical companies in relation to operating authorisations (manufacturing, wholesale, import, export, trading abroad, brokerage and agency) and special authorisations
- Advising various pharmaceutical companies in selling their products to wholesalers and medical service providers, particularly in the area of monetary benefits (discounts, kickbacks, further and continued education contributions, sponsoring, etc.)
- Advising and representing various pharmaceutical companies in the area of advertising directed to professionals and the general public
- Advising and representing various pharmaceutical companies in appeal proceedings before the Federal Administrative Court and the Federal Supreme Court in relation to the inclusion of their medicinal products in the list of reimbursable products (Specialities List) and the periodic review of the listing conditions
- Advising a world-leading medical device manufacturer on all regulatory product issues
- Advising and supporting a medical device manufacturer on product recalls
- Advising various medical device companies in the area of advertising and monetary benefits (discounts, kickbacks, sponsoring, etc.)
- Advising and representing a medical device manufacturer in an administrative criminal proceeding in relation to clinical trials
- Advising a retailer in relation to the purchase of medical devices and the implementation of its medical devices compliance programme
- Advising a retailer and a major medical device manufacturer on political initiatives to amend laws and regulations
- Advising and representing medical service providers in administrative and administrative criminal proceedings in relation to, inter alia, reprocessing of medical devices and transplants and transplant products
- Advising various service providers in relation to stem cell therapies and therapies involving cell extracts
- Advising various service providers on data protection
- Numerous M&A transactions with service providers
- Advising and representing hospitals and clinics in relation to the allocation to cantonal hospital lists and to the inter-cantonal hospital list of highly-specialised medicine (HSM)
- Advising and representing hospitals and clinics in sovereign tariff setting procedures and the associated appeal procedures, particularly in the areas of SwissDRG and TARMED
- Advising several Swiss physicians in the area of professional law, particularly advertising, monetary benefits and authorisations
- Advising physicians and clinics on tariff and other social security related issues
- Advising and representing foreign physicians in relation to the recognition of foreign further education for a Swiss specialist title
- Providing comprehensive regulatory advice to the European market leader in the area of laboratory diagnostics, particularly with regard to tariff and other social security related issues
Other activities
- Lecturer at the Swiss Federal Institute of Technology (ETHZ)
- Co-editor of the journal Life Science Recht (Stämpfli)
- Numerous scientific lectures and publications
Awards
- recommended for «Life Sciences» by Who's Who Legal Switzerland (2024)
- recommended for «Life Sciences: IP» and «Life Sciences: Regulatory» by Leaders League (2024)
- recommended for «Healthcare and Life Sciences» by Legal500 (2024)
- recommended for «Healthcare» by Chambers Europe (2024)
- recommended for «Life Sciences» by Chambers Europe (2024)
- recommended for «Healthcare and Life Sciences» by Legal500 (2023)
- Lawyer of the Year for «Life Sciences» by Legalcommunity (2022)
- recommended for «Healthcare and Life Sciences» by Legal500 (2022)
- recommended for «Life Sciences» by Who's Who Legal (2022)
- recommended for «Healthcare» by Chambers Europe (2022)
- recommended for «Life Sciences» by Chambers Europe (2022)
- recommended for «Healthcare» by Who's Who Legal (2021)
- recommended for «Healthcare and Life Sciences» by Legal500 (2021)
- recommended for «Healthcare» by Chambers Europe (2021)
- recommended for «Life Sciences» by Chambers Europe (2021)
- recommended for «Healthcare» by Who's Who Legal (2020)
Memberships
- Swiss Association of Jurists (SJV)
- Zurich Bar Association (ZAV)
- Swiss Bar Association (SAV)
- British-Swiss Chamber of Commerce (BSCC)
More from Felix Kesselring
Know-how
Presentation
Zwischen Regelung und Rätsel: Entschlüsselung der Neuregelung der Einzelfallvergütung (Art. 71a ff. KVV und Art. 38b ff. KLV)
Learn more
Publication
SWITZERLAND: An Introduction to Healthcare
The Swiss healthcare sector is currently undergoing major changes. The most noteworthy ones are discussed in the following.
Learn more
News
06.06.2024
Who's Who Legal Switzerland Report 2024
We are pleased to inform you that Bratschi Ltd. has received multiple awards in the Switzerland Report 2024 of the renowned…
Learn more
21.03.2024
Chambers Europe Rankings 2024
We are pleased to announce that Bratschi AG has been recognized in the 2024 edition of the prestigious international Chambers…
Learn more
Events
10.03.2025
HSG Intensivseminar Medtech
Das Thema des Forums lautet: «Strategisches Produkt- und Marketingmanagement in der Medizintechnik». Die Veranstaltung…
St.Gallen
Felix Kesselring